This information was published on 2023-08-28T10:23:50 for IP Right Registration Published.
| Field | Value |
| (210) | 2345712 (IR 1722241) |
| (220) |
03 Mar 2023
|
| (300) |
US, 20 Jan 2023, 97762199
|
| (511) (510) |
Class 42
Pharmaceutical drug development services; pharmaceutical research and development; product design and development in the field of pharmaceuticals; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of pharmaceuticals. |
| (540) | AMBIFECT |
| (550) | Word |
| (730) |
Akston Biosciences Corporation
|
Find out more about publications on the About page.